SUZHOU, China, March 6, 2025 /PRNewswire/ — On March 06, 2025, GenAssist Ltd (GenAssist), a pioneering gene-editing biotechnology company specializing in genome medicines, is thrilled to announce that it has received clearance from the U.S Food and Drug Administration(FDA) for its…

To Accelerate Transformation, Appoints Stephen Hayes Dacus as President & Representative Director and CEO after the Group’s Annual General Meeting in May 2025 Will Pursue IPO of 7-Eleven, Inc. (SEI, 7-Eleven in North America) by 2H 2026 Signs Definitive Agreement upon Sale of Superstore…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.